Polymorphism of podocyte protein genes in nephrotic glomerulonephritis, resistant to standard regimens of immunosupressive therapy


Cite item

Full Text

Abstract

Identification of podocyte gene mutations as an approach to recognition of the nature of the resistant nephrotic syndrome in chronic glomerulonephritis

References

  1. Brahm M., Brammer M., Balsløv J.T. et al. Prognosis in glomerulonephritis. III. A longitudinal analysis of changes in serum creatinine and proteinuria during the course of disease: effect of immunosuppressive treatment. Report from Copenhagen Study Group of Renal Diseases. J Intern Med. 1992; 231(4): 339-347.
  2. Ponticelli C. Membranous nephropathy. J Nephrol. 2007; 20: 268-287.
  3. van Husen M., Kemper M.J. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol. 2011; 26(6): 881-892.
  4. Carraro M., Caridi G., Bruschi M. et al. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2002; 13: 1946-1952.
  5. Benoit G., Machuca E., Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol. 2010; 25: 1621-1632.
  6. Machuca E., Benoit G., Antignac C. Genetics of nephritic syndrome: connecting molecular genetics to podocyte physiology. Hum Mol Genet. 2009; 18: R185-R194.
  7. Wing M.R., Bourdon D.M., Harden T.K. PLC-epsilon: a shared effector protein in Ras-, Rho-, and G alpha beta gammamediated signaling. Mol Interv. 2003; 3: 273-280.
  8. Hinkes B., Wiggins R.C., Gbadegesin R. et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet. 2006; 38: 1397-1405.
  9. Lehtonen S., Ryan J.J., Kudlicka K. et al. Cell junction-associated proteins IQGAP1, MAGI-2, CASK, spectrins, and alpha-actinin are components of the nephrin multiprotein complex. Proc Natl Acad Sci USA. 2005; 102: 9814-9819.
  10. Diez-Sampedro A., Lenz O., Fornoni A. Podocytopathy in diabetes: a metabolic and endocrine disorder. Am J Kidney Dis. 2011; 58(4): 637-646.
  11. Yuan H., Takeuchi E., Taylor G.A. et al. Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. J Am Soc Nephrol. 2002; 13: 946-956.
  12. Shea-Simonds P., Cairns T.D., Roufosse C., Cook T., Vyse T.J. Lupus podocytopathy. Rheumatology (Oxford). 2009; 48(12): 1616-1618.
  13. Boute N., Gribouval O., Roselli S. et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet. 2000; 24: 349-354.
  14. Чеботарева Н.В., Бобкова И.Н., Козловская Л.В. Нефринурия как показатель структурно-функциональных нарушений гломерулярного фильтра у больных протеинурическими формами нефрита. Клиническая нефрология. 2010; 4: 51-55.
  15. Rapola J., Sariola H., Ekblom P. Pathology of fetal congenital nephrosis: immunohistochemical and ultrastructural studies. Kidney Int. 1984; 25: 701-707.
  16. Kaukinen A., Kuusniemi A.M., Lautenschlager I., Jalanko H. Glomerular endothelium in kidneys with congenital nephrotic syndrome of the Finnish type (NPHS1). Nephrol Dial Transplant. 2008; 23: 1224-1232.
  17. Kaukinen A., Lautenschlager I., Helin H. et al. Peritubular capillaries are rarefied in congenital nephritic syndrome of the Finnish type. Kidney Int. 2009; 75: 1099-1108.
  18. Ingulli E., Tejani A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children-a single-center experience. Transplantation. 1991; 51: 401-405.
  19. Kestila M., Lenkkeri U., Mannikko M. et al. Positionally cloned gene for a novel glomerular protein-nephrin is mutated in congenital nephrotic syndrome.Mol.Cell. 1998; 1: 575-582.
  20. Lenkkeri U., Mannikko M., McCready P. et al. Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet. 1999; 64: 51-61.
  21. Philippe A., Nevo F., Esquivel E.L. et al. Nephrin mutations can cause childhood-onset steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2008; 19: 1871-1878.
  22. Laakkonen H., Lönnqvist T., Uusimaa J. et al. Muscular dystonia and athetosis in six patients with congenital nephritic syndrome of the Finnish type (NPHS1). Pediatr Nephrol. 2006; 21:182-189.
  23. Koziell A., Grech V., Hussain S. et al. Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephritic syndrome advocate a functional inter-relationship in glomerular filtration. Hum Mol Genet. 2002; 11: 379-388.
  24. Tsukaguchi H., Sudhakar A., Le T.C. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest. 2002; 110:1659-1666.
  25. Pereira A.C., Pereira A.B., Mota G.F. et al. NPHS2 R229Q functional variant is associated with micro-albuminuria in the general population. Kidney Int. 2004; 65:1026-1030.
  26. Huber T.B., Simons M., Hartleben B. et al. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet. 2003; 12:3397-3405.
  27. Roselli S., Heidet L., Sich M. et al. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol. 2004; 24: 550-560.
  28. Roselli S., Moutkine I., Gribouval O. et al. Plasma membrane targeting of podocin through the classical exocytic pathway: effect of NPHS2 mutations. Traffic. 2004; 5: 37-44.
  29. Hinkes B., Vlangos C., Heeringa S. et al. Specific Podocin Mutations Correlate With Age of Onset in Steroid-Resistant Nephrotic Syndrome J Am Soc Nephrol. 2008; 19: 365-371.
  30. Lowik M., Levtchenko E., Westra D. et al. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerrosis Nephrol Dial Transplant. 2008; 23: 3146-3151.
  31. Shih N.Y., Li J., Karpitskii V. et al. Congenital nephritic syndrome in mice lacking CD2-associated protein. Science. 1999; 286: 312-315.
  32. Kim J.M., Wu H., Green G. et al. CD2-associated protein haplo-insufficiency is linked to glomerular disease susceptibility. Science. 2003; 300: 1298-1300.
  33. Löwik M.M., Groenen P.J., Pronk I. et al. Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int. 2007; 72: 1198-1203.
  34. Kirsch K.H., Georgescu M.M., Ishimaru S., Hanafusa H. CMS: an adapter molecule involved in cytoskeletal rearrangements. Proc Natl Acad Sci U S A. 1999; 96: 6211-6216.
  35. Huber T.B., Kwoh C., Wu H. et al. Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin. J Clin Invest. 2006; 116: 1337-1345.
  36. Schwarz K., Simons M., Reiser J. et al. Podocin, a raft-associated component of the glomerular slit diaphragm interacts with CD2AP and nephrin. J Clin Invest. 2001; 108: 1621-1629.
  37. Little M., Wells C. A clinical overview of WT1 gene mutations. Hum Mutat. 1997; 9: 209-225.
  38. Haber D.A., Buckler A.J., Glaser T. et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell. 1990; 61: 1257-1269.
  39. McTaggart S.J., Algar E., Chow C.W. et al. Clinical spectrum of Denys-Drash and Frasier syndrome. Pediatr Nephrol. 2001; 16: 335-339.
  40. Игнатова М.С. Дизэмбриогенез органов мочевой системы и нефропатии. Клиническая нефрология. 2011; 4: 10-15.
  41. Чеботарева Н.В., Бобкова И.Н., Козловская Л.В., Ли О.А. Значение нарушений механизмов самозащиты почки при хроническом гломерулонефрите. Клиническая нефрология. 2011; 1: 8-14.
  42. Tipping P.G., Holdsworth S.R. Cytokines in glomerulonephritis. Semin Nephrol. 2007; 27(3): 275-285.
  43. Dimitrov S., Lange T., Fehm H.L., Born J. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav Immun. 2004; 18(4): 368-374.
  44. Tsujimura S, Tanaka Y. Treatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune disease. Clin Exp Nephrol. 2011 Aug 17. [Epub ahead of print].
  45. Jones G., Juszczak M, Kingdon E. et al. Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids. Nephrology Dialysis Transplantation <http://ndt.oxfordjournals.org/>. 2004; 12: 3160-3164.
  46. Austin H.A., Illei G.G., Braun M.J., Balow J.E. Randomized, controlled trial of prednisone, cyclophosphamide and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol. 2009; 20(4): 901-911.
  47. Ruf R.G., Lichtenberger A., Karle S.M. et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol. 2004; 15:722-732.
  48. Denamur E., Bocquet N., Mougenot B. et al. Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases. J Am Soc Nephrol. 1999; 10:2219-2223.
  49. Craigen W.J. Mitochondrial DNA mutations: an overview of clinical and molecular aspects. Methods Mol Biol. 2012; 837: 3-15.
  50. Löwik M.M., Groenen P.J., Levtchenko E.N. et al. Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis-a review. Eur J Pediatr. 2009; 168:1291-1304.
  51. Wada T., Pippin J.W., Nangaku M. et al Dexamethasone's prosurvival benefits in podocytes require extracellular signalregulated kinase phosphorylation. Nephron Exp Nephrol. 2008; 109:e8-e19.
  52. Hsu H.H., Hoffmann S., Endlich N. et al. Mechanism of angiotensin signaling on cytoskeleton of podocytes. J Mol Med. 2007; 86:1379-1394.
  53. Wang L., Flannery P.J., Rosenberg P.B. et al. Gq-dependent signaling upregulates COX2 in glomerular podocytes. J Am Soc Nephrol. 2008; 19:2108-2118.
  54. Nakajo A., Khoshnoodi J., Takenaka H. et al. Mizoribine corrects defective nephrin biogenesis by restoring intracellular energy balance. J Am Soc Nephrol. 2007; 18:2554-2564.
  55. Faul C., Donelly M., Merscher-Gomez S. et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nature Medicine. 2008; 14: 931-938.
  56. Mathieson P.W. Proteinuria and immunity-an overstated relationship? N Engl J Med. 2008; 359: 2492-2494.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies